Operating Lease, Right-of-Use Asset in USD of Imunon, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Imunon, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • Imunon, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1.08M, a 13.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Imunon, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.08M -$167K -13.4% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $1.17M -$200K -14.6% 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $986K -$501K -33.7% 31 Mar 2025 10-Q 12 May 2025
Q4 2024 $1.12M -$478K -30% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 $1.25M -$419K -25.2% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $1.37M +$81.6K +6.33% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $1.49M +$69K +4.87% 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $1.6M +$1.44M +923% 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $1.66M +$1.37M +464% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $1.29M +$858K +199% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $1.42M +$856K +152% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $156K -$535K -77.4% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $295K -$522K -63.9% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $430K -$410K -48.8% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $562K -$383K -40.5% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $691K -$356K -34% 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 $817K -$331K -28.8% 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 $840K -$404K -32.5% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $945K -$394K -29.4% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 $1.05M -$384K -26.8% 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $1.15M -$375K -24.6% 30 Sep 2020 10-Q 16 Nov 2020
Q2 2020 $1.24M -$366K -22.7% 30 Jun 2020 10-Q 14 Aug 2020
Q1 2020 $1.34M -$357K -21% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $1.43M +$332K +30.1% 31 Dec 2019 10-K 19 Mar 2021
Q3 2019 $1.52M 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $1.61M 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $1.7M 31 Mar 2019 10-Q 15 May 2019
Q4 2018 $1.1M 31 Dec 2018 10-K 29 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.